What Does Rallybio Do?

Total employees59
HeadquartersFarmington
Founded2018

Rallybio is a clinical-stage biotechnology company focused on developing and commercializing novel therapeutics for patients with severe and rare diseases. The company leverages its deep expertise in drug development and a collaborative approach to identify promising drug candidates and advance them through clinical trials. Rallybio's mission is to make a meaningful impact on the lives of individuals affected by these debilitating conditions by delivering innovative treatments where significant unmet medical needs exist. They aim to build a portfolio of therapies targeting various rare diseases, driven by scientific rigor and a patient-centric philosophy.

Where Is Rallybio's Headquarters?

HQ Function

Serves as the central hub for Rallybio's corporate management, strategic planning, research and development oversight, financial operations, and administrative functions.

Notable Features:

Located within 'The Exchange,' a modern life sciences campus, offering state-of-the-art laboratory and office facilities. Its proximity to research institutions and talent pools in Connecticut is a key feature.

Work Culture:

Rallybio fosters a work culture centered on innovation, collaboration, urgency, and a profound commitment to patients with rare diseases. It's likely characterized by scientific rigor, agility, and a team-oriented approach to tackling complex challenges in drug development.

HQ Significance:

The Farmington headquarters strategically places Rallybio within Connecticut's burgeoning bioscience corridor, facilitating access to specialized talent, academic collaborations (like nearby UConn Health), and a supportive ecosystem. It is pivotal for their R&D leadership and corporate decision-making.

Values Reflected in HQ: The headquarters' location in a dedicated life sciences hub and its advanced facilities reflect Rallybio's commitment to scientific excellence, innovation, and its mission-driven focus on developing transformative therapies.

Location:

Rallybio manages global clinical trials for its therapeutic candidates, requiring coordination across multiple countries. Its registered entity in Dublin, Ireland (Rallybio Group Limited) signifies a strategic European presence, important for regulatory interactions, clinical trial oversight, and potential future market access in the region. The company collaborates with international researchers and patient advocacy groups to advance its mission for rare diseases worldwide.

Street Address:

400 Farmington Avenue

City:

Farmington

State/Province:

CT

Country:

USA

Where Else Does Rallybio Operate Around the World?

New Haven, CT, USA

Address: 234 Church Street, Suite 1020, New Haven, CT 06510

Facilitates collaboration with local research institutions, access to specialized talent in the New Haven biotech hub, and supports R&D and business development activities.

Dublin, Ireland

Address: Rallybio Group Limited, Regus, Harcourt Centre, Dublin 2, D02 HW77

Establishes a corporate presence in the EU, crucial for managing aspects of European clinical trials, engaging with regulatory authorities like the EMA, and preparing for potential future commercial activities in Europe.

Buying Intent Signals for Rallybio

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Who's Leading Rallybio? Meet the Executive Team

As of April 2025, Rallybio' leadership includes:

Martin Mackay, Ph.D. - Chairman and Chief Executive Officer
Stephen Uden, M.D. - Co-Founder and Chief Operating Officer
Jeffrey M. Fryer, CPA - Co-Founder and Chief Financial Officer
Petra Kaufmann, M.D., M.Sc. - Chief Medical Officer
Jonathan I. Lieber - Chief Legal Officer
Douglas Sheridan, M.S. - Chief Development Officer

Who's Investing in Rallybio?

Rallybio has been backed by several prominent investors over the years, including:

5AM Ventures
Canaan Partners
F-Prime Capital
Pivotal bioVenture Partners
RA Capital Management
Sofinnova Investments
Viking Global Investors
TPG's The Rise Fund

What Leadership Changes Has Rallybio Seen Recently?

Hire2
Exits0

Over the past year, Rallybio has significantly strengthened its executive leadership team with key strategic appointments. The company onboarded a new Chief Medical Officer and a new Chief Development Officer, underscoring its commitment to advancing its clinical pipeline and enhancing its drug development capabilities. These hires bring valuable expertise in rare diseases and clinical operations.

New Appointments:

Petra Kaufmann, M.D., M.Sc., Dr. Petra Kaufmann appointed as new Chief Medical Officer to lead clinical and medical affairs.
Douglas Sheridan, M.S., Douglas Sheridan appointed as new Chief Development Officer to oversee development programs.

What Technology (Tech Stack) Is Used byRallybio?

Discover the tools Rallybio uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

Rallybio Email Formats and Examples

Rallybio commonly uses the email format of the employee's first initial followed by their last name. This is a standard convention in many corporations, particularly within the biotechnology and pharmaceutical sectors.

[first_initial][last]@rallybio.com

Format

mmackay@rallybio.com

Example

85%

Success rate

What's the Latest News About Rallybio?

GlobeNewswireMay 9, 2024

Rallybio Reports First Quarter 2024 Financial Results and Recent Highlights

Rallybio announced its financial results for the first quarter of 2024 and provided updates on its clinical programs, including progress on RLYB212 for preventing Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT) and RLYB116 for complement-mediated diseases....more

GlobeNewswireMarch 26, 2024

Rallybio Announces First Participant Dosed in Phase 2 Study of RLYB212 for Prevention of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT)

Rallybio announced the dosing of the first participant in its Phase 2 globally-conducted clinical study evaluating RLYB212, an anti-HPA-1a monoclonal antibody, for the prevention of FNAIT....more

GlobeNewswireJanuary 4, 2024

Rallybio Announces Strategic Priorities and Anticipated 2024 Milestones

Rallybio outlined its key strategic priorities for 2024, focusing on advancing its clinical pipeline, particularly RLYB212 for FNAIT prevention and RLYB116 for complement-mediated diseases, and managing its capital resources....more

Highperformr's free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including Rallybio, are just a search away.